Should you wish to receive an email alert when this page is updated with a new press release, please register with our Alert Service.



Date Title
11/12/2009 Cosmo’s CB-03-01 phase II pilot study in acne demonstrates superiority over Retin A®
08/12/2009 Cosmo Pharmaceuticals publishes Public Tender Offer for BioXell
03/12/2009 Cosmo Pharmaceuticals reports completion of enrolment in Phase III EU study of Budesonide MMX® for Ulcerative Colitis
18/11/2009 Cosmo Pharmaceuticals offers to acquire BioXell
30/07/2009 Cosmo reports a strong first half-year 2009
23/03/2009 Cosmo reports strong revenue growth, €9.4 million net profit for 2008 and a confident outlook for 2009


Back to top